Impact of Seizure Recurrence on 1-Year Functional Outcome and Mortality in Patients With Poststroke Epilepsy

Hajime Yoshimura1, Tomotaka Tanaka1, Kazuki Fukuma1

  • 1From the Department of Neurology (H.Y., M. Kawamoto), Kobe City Medical Center General Hospital; Department of Neurology (T.T., K.F., M.I.), National Cerebral and Cardiovascular Center, Suita; Department of Neurology (S. Matsubara), Graduate School of Medical Sciences, Kumamoto University; Department of Neurology and Brain Bank for Aging Research (R. Motoyama, S. Murayama), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology; Department of Neurology (M.M.), Nakamura Memorial Hospital, Sapporo; Minami-ichijyo Neurology Clinic (M.M.), Sapporo; Department of Neurology (T.M.), St. Mary's Hospital, Fukuoka; Department of Neurology (Y.M.), National Hospital Organization Okayama Medical Center; Department of Neurology (J.S.), Toyota Memorial Hospital; Department of Neurology (K.K., A.S., R.T.), Kyoto University Graduate School of Medicine; Department of Preventive Medicine and Epidemiology (K.N.), National Cerebral and Cardiovascular Center, Suita; Department of Medical Informatics and Clinical Epidemiology (D.O.), Graduate School of Medical Science, Kyoto Prefectural University of Medicine; Department of Cerebrovascular Medicine (M. Koga, K.T.), National Cerebral and Cardiovascular Center, Suita; Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders (S. Murayama), Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Suita; Division of Neurology (R. Matsumoto), Kobe University Graduate School of Medicine; and Department of Epilepsy, Movement Disorders and Physiology (A.I.), Kyoto University Graduate School of Medicine, Japan.

Neurology
|May 4, 2022
PubMed
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
304
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
629
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
473
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
300